Sharekhan

Rossari Biotech Ltd

Mon 2/02/2026,15:59:59 | NSE : ROSSARI

₹ 528.80-6.70 (-1.25%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 535.00

Previous Close

₹ 535.50

Volume

100015

Mkt Cap ( Rs. Cr)

₹2928.67

High

₹ 555.00

Low

₹ 522.05

52 Week High

₹ 766.00

52 Week Low

₹ 501.90

Book Value Per Share

₹ 225.97

Dividend Yield

0.09

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Rossari Biotech Ltd

Your Vote -

Buy

28.55%

Hold

46.22%

Sell

25.23%

28.55%

662 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

528.80

39

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

39

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Rossari Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rossari Biotech - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    29 Jan 2026, 6:26PM Receipt of award in relation to arbitration proceedings in connection with Unitop ChemicalsPrivate Limited.
  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015

    29 Jan 2026, 6:26PM Receipt of award in relation to arbitration proceedings in connection with Unitop Chemicals Private Limited.
  • Rossari Biotech - Updates

    23 Jan 2026, 8:08PM Intimation under Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements), 2015
  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015

    23 Jan 2026, 8:07PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015.
  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Jan 2026, 7:57PM Intimation of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19, 2026.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    23 Jan 2026, 7:56PM Intimation of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19, 2026.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    19 Jan 2026, 6:38PM Audio recording of Earnings Conference Call for Q3 FY 26.
  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Jan 2026, 6:38PM Audio recording of Earnings Conference Call for Q3 FY 26.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Jan 2026, 11:48AM Rossari Biotech Limited informed the Exchange regarding Press Release dated January 17, 2026 titled \ Rossari Biotech announces Q3 FY 26 Results\.
  • Rossari Biotech - Press Release

    18 Jan 2026, 4:10PM Rossari Biotech Limited informed the Exchange regarding Press Release dated January 17, 2026 titled ""Rossari Biotech announces Q3 FY 26 results""
  • Rossari Biotech - Investor Presentation

    18 Jan 2026, 3:59PM Rossari Biotech Limited has informed the Exchange about Investor Presentation
  • Rossari Biotech - Copy of Newspaper Publication

    18 Jan 2026, 3:40PM Newspaper Publication of extract of Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation

    18 Jan 2026, 4:01PM Intimation of Q3 & 9M FY26- Earnings Presentation.
  • Rossari Biotech - General Updates

    17 Jan 2026, 4:20PM Intimation under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    17 Jan 2026, 4:20PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    17 Jan 2026, 4:13PM Intimation of allotment of 2000 Equity Shares under Rossari Employee Stock Option Plan- 2019.
  • Rossari Biotech - ESOP/ESOS/ESPS

    17 Jan 2026, 4:11PM Intimation of allotment of 2000 Equity Shares under Rossari Employee Stock Option Plan- 2019.
  • Rossari Biotech - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31,

    17 Jan 2026, 4:07PM Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2025.
  • Rossari Biotech - Outcome of Board Meeting

    17 Jan 2026, 4:00PM Outcome of Board Meeting held on January 17, 2026.
  • Rossari Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On January 17, 2026.

    17 Jan 2026, 3:59PM Outcome of Board Meeting held on January 17, 2026.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jan 2026, 6:44PM Intimation of Earning Conference Call for investor and analyst on Monday, January 19, 2026 at 04:00 P.M. (IST).
  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Jan 2026, 6:44PM Intimation of Earning Conference Call for investor and analyst on Monday, January 19, 2026 at 04:00 P.M. (IST).
  • Rossari Biotech - Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And

    9 Jan 2026, 11:24PM Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2026 ,inter alia, to consider and
  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    9 Jan 2026, 8:51PM As of December 2025, 68.15% is owned by Indian Promoters and 31.84% by Public. <p align=justify> Institutional holds 20.57% (Insurance Companies 4.18%
  • Rossari Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Jan 2026, 5:11PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.
  • Rossari Biotech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    5 Jan 2026, 5:11PM Rossari Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Rossari Biotech - Trading Window

    29 Dec 2025, 7:06PM Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,
  • Rossari Biotech - General Updates

    18 Dec 2025, 4:22PM Incorporation of Rossari (Singapore) Pte. Ltd., in Republic of Singapore, wholly owned subsidiary of Rossari Biotech Limited.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    18 Dec 2025, 4:22PM Incorporation of Rossari (Singapore) Pte. Ltd., in Republic of Singapore, wholly owned subsidiary of Rossari Biotech Limited.
  • Rossari Biotech - Outcome of Board Meeting

    18 Dec 2025, 11:46AM The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.
  • Rossari Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On December 18, 2025.

    18 Dec 2025, 11:45AM The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Republic of Singapore and other matters.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Credit Rating

    3 Dec 2025, 6:59PM Intimation of affirmation of Credit Rating.
  • Rossari Biotech - Credit Rating

    3 Dec 2025, 6:58PM Rossari Biotech Limited has informed the Exchange about Credit Rating
  • Rossari Biotech - Updates

    24 Nov 2025, 9:08PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015
  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015

    24 Nov 2025, 9:07PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015
  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Nov 2025, 6:37PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.
  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Nov 2025, 6:36PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.\r\n
  • Rossari Biotech

    20 Oct 2022 , 10:21AM RBL has approved the incorporation of a wholly owned subsidiary in Bangladesh with an estimate aggregate Capital outlay of BDT 300 million (approximately Rs. 25 Crore). The Wholly Owned Subsidiary will enable the Company to expand the market for RBL products in Bangladesh. Positive for the stock
  • Rossari Biotech

    19 Jul 2021 , 10:22AM Rossari Biotech Limited (Rossari): The company has approved the acquisition of Tristar Intermediates Pvt. Ltd. As per the agreement, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates. 76% of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next 3 years. The total enterprise value of the transaction is Rs. 120 crores. Rossari plans to fund the investment through cash on balance sheet and doesn’t intend to raise any debt for this acquisition. The transaction will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term. The synergistic acquisition provides Rossari with enhanced portfolio of products, stronger presence in new & untapped international markets and access to newer technologies.
  • Rossari Biotech debuts at 58% premium

    23 Jul 2020 , 10:46AM Rossari Biotech lists at Rs. 670/Sh against the issue price of Rs. 425/Sh

Key fundamentals

Evaluate the intrinsic value of Rossari Biotech Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1107.318 1015.386 923.612 784.524 404.444
Liabilities 1107.318 1015.386 923.612 784.524 404.444
Equity 11.073 11.049 11.031 11.011 10.386
Gross Profit 186.235 161.254 122.648 122.793 120.855
Net Profit 114.742 99.645 71.39 79.474 79.102
Cash From Operating Activities 92.198 73.918 113.66 33.116 52.093
NPM(%) 8.01 8.28 7.32 7.4 11.45
Revenue 1431.628 1202.91 975.172 1072.844 690.414
Expenses 1245.393 1041.656 852.524 950.051 569.559
ROE(%) 9.16 7.96 5.7 6.35 6.32

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
20 Jun 2025 0.5 25 0.09 699.35
16 Aug 2024 0.5 25 0.09 780.3
24 May 2023 0.5 25 0.09 695.5
07 Jul 2022 0.5 25 0.09 888.75
08 Sep 2021 0.5 25 0.09 1282.15

Peers

Other companies within the same industry or sector that are comparable to Rossari Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 10.90 -4.39 4.95 634.26 20.78 0.00
Shreeoswal Seeds and Chemicals Ltd 13.19 -0.15 12.10 4871.24 19.29 0.00
GRM Overseas Ltd 162.89 -0.75 44.14 3195.30 164.61 0.00
Jain Irrigation Systems Ltd 35.89 -1.21 43.77 36805.60 23.46 0.00

Company Info

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

Read More

Parent Organisation

Rossari Biotech Ltd.

Founded

10/08/2009

Managing Director

Mr.Sunil Chari

NSE Symbol

ROSSARIEQ

FAQ

The current price of Rossari Biotech Ltd is ₹ 528.80.

The 52-week high for Rossari Biotech Ltd is ₹ 555.00 and the 52-week low is ₹ 522.05.

The market capitalization of Rossari Biotech Ltd is currently ₹ 2928.67. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Rossari Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Rossari Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Rossari Biotech Ltd shares.

The CEO of Rossari Biotech Ltd is Mr.Sunil Chari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT